May 22, 2020

Strategic Technology Trends in the Migraine Drugs Market

Migraine Drugs Market is valued around USD 2014.1 Billion in 2019 and expected to reach USD 2971.9 Billion by 2030 with the CAGR of 3.6% over the forecast period.

Migraine Drugs are used for the treatment of neurological condition called as migraine. This condition involves the high intensity headache which can last from hours up to days with several other symptoms such as vomiting, nausea, sensitivity towards light, smell & other. There has been study which proves that female population is more prone to migraine as compared to the males. Migraine is highly manageable disorder with the help of proper medication & slight change in the lifestyle.

Global Migraine Drugs Market report is segmented on the basis of type, administration route, distribution channel and by regional. Based upon type, the migraine drugs market is fragmented into abortive medicine and preventive medicine. On the basis of administration route, the market is categorized into oral, injection and others. Based on distribution channel, the market is fragmented into hospital-based pharmacies, retail pharmacies, and online pharmacies. The regional bifurcation of countries includes North America, Europe, Asia-Pacific, and RoW which are further segmented into major countries such as U.S., UK, France, and others.

The migraine drugs market is mainly driven by the high prevalence rate of migraine along with growing awareness among people which in turn created the demand for migraine drugs. There has been technological advancement with robust product pipeline along with constant product launch. In addition, growing healthcare expenditure as well as FDA approvals to novel therapies for the better management of migraine is also expected to contribute market growth. On the other hand, constant growth in female population accompanied by rising awareness with respect to treatment & prevention of migraine followed by the various organizations aim to further create awareness among large population has anticipated the market growth. However, various side effects associated with the migraine drugs restrain the market growth in near future.

Download sample copy of this report at

The developed regions such as North America and Europe are expected to hold the major market share owing to the presence of major market players in the region followed by technological advancement with rapid use of novel therapies. Asia Pacific is expected to dominate the migraine drugs market in terms of growth rate owing to the high prevalence rate along with huge female population. Moreover, rising healthcare expenditure along with growing awareness among people with regards to the treatment & prevention of migraine are also expected to support the market growth over the forecast period.

The major market players profiled in the migraine drugs market includes Allergan Plc., AstraZeneca, GlaxoSmithKline Plc., Impax Laboratories, Abbott Laboratories, Eisai Co., Ltd., Johnson & Johnson, Merck & Co., Endo International Plc, and Pfizer Inc. among others.

About Us:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

Contact US:

Joseph Lawrence (Head - Client Engagement & Servicing)

[email protected]